Discover published sets by community

Class: Class III, Mechanism of action: Potassium channel blocker, also blocks sodium and calcium channels and has alpha- and beta-blocking properties, Indications: Life-threatening ventricular arrhythmias, atrial fibrillation

Class: Class Ib, Mechanism of action: Sodium channel blocker, primarily affecting ventricular cells, Indications: Acute ventricular arrhythmias especially post-MI

Class: Class II, Mechanism of action: Non-selective beta-blocker, Indications: Supraventricular and ventricular arrhythmias, prevention of MI recurrence

Class: Class Ia, Mechanism of action: Sodium channel blocker with anticholinergic activity, Indications: Supraventricular and ventricular arrhythmias

Class: Class Ic, Mechanism of action: Sodium channel blocker with little effect on AP duration, Indications: Supraventricular arrhythmias, atrial fibrillation/flutter

Class: Class III, Mechanism of action: Beta-blocker with potassium channel blocking properties, Indications: Atrial fibrillation/flutter, ventricular arrhythmias

Class: Class III, Mechanism of action: Selective potassium channel blocker, Indications: Atrial fibrillation/flutter conversion and maintenance of sinus rhythm

Class: Class Ia, Mechanism of action: Sodium channel blocker with some potassium channel effects, Indications: Acute ventricular arrhythmias, atrial fibrillation

Class: Class IV, Mechanism of action: Calcium channel blocker with both vascular and cardiac effects, Indications: Supraventricular tachycardia, rate control in atrial fibrillation/flutter

Class: Cardiac glycoside, Mechanism of action: Inhibition of Na+/K+ ATPase leading to increased intracellular calcium, Indications: Atrial fibrillation, heart failure

Class: Class Ia, Mechanism of action: Sodium channel blocker, Indications: Ventricular tachycardia, certain forms of supraventricular tachycardia

Class: Unassigned, Mechanism of action: Activates adenosine receptors, leading to hyperpolarization and conductance decrease in AV node, Indications: Paroxysmal Supraventricular Tachycardia (PSVT)

Class: Class IV, Mechanism of action: Calcium channel blocker, Indications: Supraventricular arrhythmias, rate control in atrial fibrillation/flutter

Class: Class II, Mechanism of action: Selective beta1-blocker, Indications: Supraventricular and ventricular arrhythmias, hypertension, post-MI

Class: Class II, Mechanism of action: Short-acting selective beta1-blocker, Indications: Supraventricular tachycardias, intraoperative and perioperative tachycardia

Class: Class II, Mechanism of action: Non-selective beta-blocker, Indications: Supraventricular and ventricular arrhythmias, angina pectoris

Class: Class Ic, Mechanism of action: Sodium channel blocker, Indications: Supraventricular and ventricular arrhythmias, atrial fibrillation/flutter prevention

Class: Class III, Mechanism of action: Potassium channel blocker, Indications: Conversion of recent-onset atrial fibrillation and flutter

Class: Class Ib, Mechanism of action: Sodium channel blocker similar to Lidocaine, Indications: Ventricular tachycardia, prevention of ventricular arrhythmias